Health & Wellness
The intersection of cellular rejuvenation, precision metabolic medicine, disease prevention, and evidence-based longevity science.
Metabolic Incretins & Peptides
Beyond GLP-1: Multi-receptor agonists preserving skeletal muscle mass and reversing hepatic steatosis.
Nutritional Epigenomics
How dietary methyl donors and intermittent fasting modulate NAD+ biosynthesis and sirtuin activation.
Neuro-Psychiatric Biomarkers
Blood-based assays for phosphorylated tau (p-tau217) and neurofilament light chain (NfL) in early cognitive decline.
Preventive Cardiovascular Science
Single-dose GalNAc-siRNA targeting Lipoprotein(a) and PCSK9 to permanently reduce lifetime atherogenic risk.
Latest Medical Discoveries & Clinical Readouts
Evidence-Based Signal
Rewriting the Epigenetic Clock: Can Partial Reprogramming Reverse Human Tissue Aging?
For decades, cellular aging was viewed as an irreversible thermodynamic decline. Today, epigenetic reprogramming is transforming senescence from an inevitable fate into an engineering challenge.
The Q3 BioCapital Report: $14B Deployed into Next-Gen Conjugates and Degitizers
An exclusive breakdown of global life science venture allocations, private valuations, and the reopening of the public biotech IPO window.
Beyond Semaglutide: The Next-Gen Incretin Wave and Muscle-Preserving Peptides
Weight loss is no longer the clinical challenge—preserving lean skeletal muscle and metabolic rate is. The clinical pipeline of multi-receptor peptides is redefining obesity pharmacotherapy.